Research and basic information on subjects ranging from tuberculosis surveillance to adolescent health disappeared from ...

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Get all the news you need in your inbox each morning. Among the first webpages to come down were in the health sphere. The Centers for Disease Control page containing data on ...

In the past two weeks, the Trump administration has spent a remarkable amount of time undoing health orders—not just the Biden administration’s rules, but also its own jarring crackdown. On day two of ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...

In response to the growing demand for peptide drugs, Cytovance Biologics and PolyPeptide have announced a partnership that combines Cytovance’s expertise in microbial and mammalian expression ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A group of health care experts said that if the Arizona Supreme Court issues a death warrant, it would trigger "a cascade of ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.